MedPath

ADINA vs. High Flow Nasal Cannula Comparison Study

Not Applicable
Not yet recruiting
Conditions
Respiratory Distress Neonatal
Interventions
Device: Adaptive Dynamic Inspiratory Nasal Apparatus
Device: High flow Nasal Canula
Registration Number
NCT03171129
Lead Sponsor
Loma Linda University
Brief Summary

This study is to evaluate the feasibility of using a pressure limited nasal cannula system instead of a high flow nasal cannula system in the management of premature babies with respiratory distress.

Detailed Description

NCPAP has been used increasingly to manage respiratory distress in newborns as well as apnea of prematurity. Humidified high flow nasal cannula devices (flows 1-8 lpm) have also been used in neonatal intensive care units.

This study is to evaluate the feasibility of using a pressure limited nasal cannula system instead of a high flow nasal cannula system in the management of premature babies with respiratory distress.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Neonates admitted to NICU
  • Weights of 400-500 grams
  • Requiring oxygen greater than 30%
  • No evidence of focal lobar consolidation in lung fields
Exclusion Criteria
  • Intolerance to procedure
  • gelatinous skin
  • known allergy to adhesive material
  • interference with therapy
  • profound sepsis
  • pneumonia
  • unmanaged apnea/bradycardia
  • known or suspect complex congenital heart disease
  • severe cleft lip or palate
  • suspect or proven lethal congenital anomaly
  • intolerance to the interface used in the devices
  • inability to secure an appropriate fit of the patient nasal interface
  • considered non-viable or of uncertain viability
  • parental refusal.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High flow nasal cannula system w/ ADINAAdaptive Dynamic Inspiratory Nasal ApparatusThe intervention is the insertion of the the ADINA device into the high flow nasal cannula system. ADINA will be placed according to weight class recommendations to increase the positive end expiratory pressure (PEEP). ADINA is actually a combination of the Neotech RAM Cannula and a clear Regulator/Pop off valve.
high flow nasal cannula systemHigh flow Nasal CanulaHigh flow nasal cannula will deliver oxygen at 2-4 lpm of flow. High flow cannula are used to provide the control interface.
Primary Outcome Measures
NameTimeMethod
Duration of Oxygen UseFrom time of randomization until time of discharge from the Neonatal Intensive Care Unit (NICU) up to 100 days.

The length of time the patient is on oxygen will be measured in hours.

Secondary Outcome Measures
NameTimeMethod
Number of Participants with Excoriation at Nasal SiteFrom time of randomization until time of discharge from NICU up to 100 days.

Participants will be monitored for excoriation at the nasal site while on ADINA and/or high flow nasal cannula. The incidence of excoriation at the nasal site in each Arm will be collected for comparison.

Oxygen ConcentrationFrom time of randomization until time of discharge from NICU up to 100 days.

ADINA will provide a concentration of oxygen between 1.5 and 4 liters which is equivalent to that provided by the conventional nasal cannula. This will be measured every twelve hours by NICU staff.

Number of Participants with treatment-related pneumothoraxFrom time of randomization until time of discharge from NICU up to 100 days.

Participants will be monitored for pneumothorax occurrence while on ADINA and/or high flow nasal cannula. The incidence of pneumothorax occurrence in each Arm will be collected for comparison.

Trial Locations

Locations (1)

Loma Linda University Medical Center

🇺🇸

Loma Linda, California, United States

© Copyright 2025. All Rights Reserved by MedPath